α4β2 Nicotinic Acetylcholine Receptor Activation Ameliorates Impairment of Spontaneous Alternation Behavior in Stroke-Prone Spontaneously Hypertensive Rats, an Animal Model of Attention Deficit Hyperactivity Disorder
Authors:
- Ken-Ichi UenoKUKen-Ichi Ueno
- Hideya SaitoHSHideya Saito
- 1 July 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 302 (1) , 95-100
Abstract
The objective of the present study was to elucidate the role of nicotine in impairment of spontaneous alternation behavior of juvenile stroke-prone spontaneously hypertensive rats (SHRSP), an animal model of attention deficit hyperactivity disorder (ADHD). Spontaneous alternation behavior assessed by a Y-maze task was significantly lower, and total arm entries were significantly higher in SHRSP than in genetic control Wistar-Kyoto rats. Nicotine (0.1–1 mg/kg, s.c.) dose dependently improved the spontaneous alternation deficit without affecting total arm entries in SHRSP. Nicotine-induced (1 mg/kg, s.c.) improvement was significantly abolished by the centrally acting nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine (1 mg/kg, i.p.), but not by peripherally acting hexamethonium (5 mg/kg, i.p.), suggesting that nicotine-induced improvement is mediated via central nAChR. The α4β2 nAChR antagonist dihydro-β-erythroidine (3–10 mg/kg, i.p.) dose dependently counteracted nicotine-induced improvement of spontaneous alternation in SHRSP, whereas the α7 nAChR antagonist methyllycaconitine (3–10 mg/kg, i.p.) did not. In addition, the α4β2 nAChR agonist RJR-2403 (N-methyl-4-(3-pyridinyl)-3-butene-1-amine; 1–10 mg/kg, s.c.) dose dependently and significantly improved the spontaneous alternation deficit. These findings revealed that nicotine improved spontaneous alternation behavior in SHRSP via the activation of α4β2, but not α7, nAChR. Thus, the α4β2 nAChR mechanism might be responsible for the spontaneous alternation deficit in juvenile SHRSP, an animal model of ADHD. This evidence indicates the possibility that selective α4β2 nAChR agonists might be useful for treating attentional dysfunction in ADHD.Keywords
This publication has 37 references indexed in Scilit:
- Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder.Experimental and Clinical Psychopharmacology, 2001
- Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memoryNeuropharmacology, 2000
- AR-R 17779, an α7 nicotinic agonist, improves learning and memory in ratsBehavioural Pharmacology, 1999
- Cholinergic Changes in the Hippocampus of Stroke-Prone Spontaneously Hypertensive RatsStroke, 1996
- Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorderJournal of Substance Abuse, 1995
- Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strainsPhysiology & Behavior, 1993
- The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulantsBehavioral and Neural Biology, 1992
- The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: Effects of methylphenidate on exploratory behaviorBehavioral and Neural Biology, 1990
- Dysfunction of choline transport system through blood-brain barrier in stroke-prone spontaneously hypertensive rats.Journal of Pharmacobio-Dynamics, 1990
- Dopaminergic involvement in attention a novel animal modelProgress in Neuro-Psychopharmacology, 1981